Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 7 minute read Pharma Industry News MapLight Therapeutics sets sights on Nasdaq IPO as CNS pipeline advances toward pivotal trials MapLight Therapeutics files for Nasdaq IPO to raise $250M for schizophrenia and Alzheimer’s trials. Find out what’s next for this neuroscience innovator. bySrinathOctober 18, 2025